19 results for author:"Arzt E." in Literature citations
Results Customize
› Repeat search in UniProtKB (9)
| Underlying mechanisms of cAMP- and glucocorticoid-mediated inhibition of FasL expression in activation-induced cell death. Liberman A.C., Refojo D., Antunica-Noguerol M., Holsboer F., Arzt E. Mol. Immunol. 50:220-235(2012) · Mapped (3) |
| RSUME is implicated in HIF-1-induced VEGF-A production in pituitary tumour cells. Shan B., Gerez J., Haedo M., Fuertes M., Theodoropoulou M., Buchfelder M., Losa M., Stalla G.K., Arzt E., Renner U. Endocr. Relat. Cancer 19:13-27(2012) · Mapped (19) |
| The serine/arginine-rich protein SF2/ASF regulates protein sumoylation. Pelisch F., Gerez J., Druker J., Schor I.E., Munoz M.J., Risso G., Petrillo E., Westman B.J., Lamond A.I., Arzt E. et al. Proc. Natl. Acad. Sci. U.S.A. 107:16119-16124(2010) · Mapped (6) |
| Pituitary tumors: cell type-specific roles for BMP-4. Labeur M., Paez-Pereda M., Haedo M., Arzt E., Stalla G.K. Mol. Cell. Endocrinol. 326:85-88(2010) · Mapped (2) |
| Differential gene expression in models of pituitary prolactin-producing tumoral cells. Giacomini D., Haedo M., Gerez J., Druker J., Paez-Pereda M., Labeur M., Stalla G.K., Arzt E. Horm. Res. 71 Suppl 2:88-94(2009) · Mapped (5) |
| Glucocorticoids inhibit GATA-3 phosphorylation and activity in T cells. Liberman A.C., Druker J., Refojo D., Holsboer F., Arzt E. FASEB J. 23:1558-1571(2009) · Mapped (12) |
| RSUME, a small RWD-containing protein, enhances SUMO conjugation and stabilizes HIF-1alpha during hypoxia. Carbia-Nagashima A., Gerez J., Perez-Castro C., Paez-Pereda M., Silberstein S., Stalla G.K., Holsboer F., Arzt E. |
| The activated glucocorticoid receptor inhibits the transcription factor T-bet by direct protein-protein interaction. Liberman A.C., Refojo D., Druker J., Toscano M., Rein T., Holsboer F., Arzt E. FASEB J. 21:1177-1188(2007) · Mapped (11) |
| Bone morphogenetic protein-4 inhibits corticotroph tumor cells: involvement in the retinoic acid inhibitory action. Giacomini D., Paez-Pereda M., Theodoropoulou M., Labeur M., Refojo D., Gerez J., Chervin A., Berner S., Losa M., Buchfelder M. et al. Endocrinology 147:247-256(2006) · Mapped (11) |
| Corticotropin-releasing hormone activates ERK1/2 MAPK in specific brain areas. Refojo D., Echenique C., Muller M.B., Reul J.M., Deussing J.M., Wurst W., Sillaber I., Paez-Pereda M., Holsboer F., Arzt E. Proc. Natl. Acad. Sci. U.S.A. 102:6183-6188(2005) · Mapped (1) |
| Involvement of the gp130 cytokine transducer in MtT/S pituitary somatotroph tumour development in an autocrine-paracrine model. Graciarena M., Carbia-Nagashima A., Onofri C., Perez-Castro C., Giacomini D., Renner U., Stalla G.K., Arzt E. Eur. J. Endocrinol. 151:595-604(2004) · Mapped (5) |
| Nur77 induction and activation are necessary for interleukin-1 stimulation of proopiomelanocortin in AtT-20 corticotrophs. Kovalovsky D., Paez Pereda M., Labeur M., Renner U., Holsboer F., Stalla G.K., Arzt E. FEBS Lett. 563:229-233(2004) · Mapped (2) |
| Functional in vitro studies on the role and regulation of interleukin-6 in human somatotroph pituitary adenomas. Thiele J.O., Lohrer P., Schaaf L., Feirer M., Stummer W., Losa M., Lange M., Tichomirowa M., Arzt E., Stalla G.K. et al. Eur. J. Endocrinol. 149:455-461(2003) · Mapped (5) |
| Laminin inhibits lactotroph proliferation and is reduced in early prolactinoma development. Kuchenbauer F., Theodoropoulou M., Hopfner U., Stalla J., Renner U., Tonn J.C., Low M.J., Arzt E., Stalla G.K., Paez-Pereda M. Mol. Cell. Endocrinol. 207:13-20(2003) · Mapped (1) |
| Involvement of bone morphogenetic protein 4 (BMP-4) in pituitary prolactinoma pathogenesis through a Smad/estrogen receptor crosstalk. Paez-Pereda M., Giacomini D., Refojo D., Nagashima A.C., Hopfner U., Grubler Y., Chervin A., Goldberg V., Goya R., Hentges S.T. et al. Proc. Natl. Acad. Sci. U.S.A. 100:1034-1039(2003) · Mapped (9) |
| Reduced expression of the cytokine transducer gp130 inhibits hormone secretion, cell growth, and tumor development of pituitary lactosomatotrophic GH3 cells. Castro C.P., Giacomini D., Nagashima A.C., Onofri C., Graciarena M., Kobayashi K., Paez-Pereda M., Renner U., Stalla G.K., Arzt E. Endocrinology 144:693-700(2003) · Mapped (2) |
| Increased splenocyte proliferative response and cytokine production in beta-endorphin-deficient mice. Refojo D., Kovalovsky D., Young J.I., Rubinstein M., Holsboer F., Reul J.M., Low M.J., Arzt E. J. Neuroimmunol. 131:126-134(2002) · Mapped (1) |
| Transforming growth factor-beta stimulates vascular endothelial growth factor production by folliculostellate pituitary cells. Renner U., Lohrer P., Schaaf L., Feirer M., Schmitt K., Onofri C., Arzt E., Stalla G.K. Endocrinology 143:3759-3765(2002) · Mapped (7) |
| Molecular and functional evidence for in vitro cytokine enhancement of human and murine target cell sensitivity to glucocorticoids. TNF-alpha priming increases glucocorticoid inhibition of TNF-alpha-induced cytotoxicity/apoptosis. Costas M., Trapp T., Pereda M.P., Sauer J., Rupprecht R., Nahmod V.E., Reul J.M., Holsboer F., Arzt E. J. Clin. Invest. 98:1409-1416(1996) · Mapped (4) |